EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Injectable Autocatalytic Hydrogel Triggers Pyroptosis to Stimulate Anticancer Immune Response for Preventing Postoperative Tumor Recurrence

Zhiping Rao, Yutong Zhu, Zhuang Chen, Yi Luo, Zuo Yang, Weijing Liu, Chaoqiang Qiao, Yuqiong Xia, Peng Yang, Dong-Man Ye, Zhongliang Wang iD

Advanced Science · 2025-01 · 12 (1)

DOI: 10.1002/advs.202408415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 28.10.2024. Verfasst von Zhiping Rao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of…. Hauptthemen laut MEDLINE: Pyroptosis, Neoplasm Recurrence, Local, Hydrogels, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key Research and Development Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modulating immunosuppression while eliminating residual microscopic tumors is critical for inhibiting the postoperative recurrence of triple‐negative breast cancer (TNBC). Although immunotherapy has shown potential in achieving this goal, due to multiple immunosuppression and poor immunogenicity of apoptosis, a satisfactory anti‐recurrence effect still faces the challenge. Herein, an injectable hydrogel‐encapsulated autocatalytic copper peroxide (CP@Gel) therapeutic platform is designed and combine it with the clinical‐grade DNA methyltransferase inhibitor decitabine (DAC) to effectively inhibit TNBC growth and postoperative recurrence via pyroptosis, killing residual cancer cells that bypass apoptosis resistance while also improving immunogenicity and modulating immunosuppression to achieve an intense anti‐tumor immune response. Following injection of the CP@Gel, the sustained release of CP leads to the autocatalytic generation of reactive oxygen species, resulting in caspase‐3 activation, and the pre‐administered DAC inhibits the methylation of Gsdme to elevate the GSDME protein levels, leading to intense pyroptosis and anti‐tumor immune responses. The in vivo results show a 67% elimination of local tumor recurrence via treatment with DAC+CP@Gel, suggesting the successful integration of sustained drug release with autocatalysis and epigenetic modification. The results thus suggest great potential for pyroptosis‐based and injectable hydrogel‐aided strategies for preventing the postoperative recurrence of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNeoplasm Recurrence, LocalHydrogelsTriple Negative Breast NeoplasmsAnimalsMiceFemaleHumansDisease Models, AnimalDecitabineCell Line, TumorImmunotherapy

Stichwörter der Autor:innen

hydrogelimmune responsepostsurgical recurrencepyroptosistriple‐negative breast cancer

Substanzen

HydrogelsDecitabine

Autor:innen und Institutionen

  • Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of Life Science and Technology, Xidian University & International Joint…
  • Medical college, Xi'an International University, Xi'an, Shaanxi, 710077, P. R. China.
  • Department of Medical Imaging, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, P. R. China.

ORCID-Profile: Zhongliang Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Research and Development Program of Shaanxi
  • Innovation Capability Support Program of Shaanxi
  • Shaanxi Fundamental Science Research Project for Chemistry and Biology
  • Natural Science Basic Research Program of Shaanxi
  • Xidian University Specially Funded Project for Interdisciplinary Exploration
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Rao, Z., Zhu, Y., Chen, Z., Luo, Y., Yang, Z., Liu, W., Qiao, C., Xia, Y., Yang, P., Ye, D. M., & Wang, Z. (2025). Injectable Autocatalytic Hydrogel Triggers Pyroptosis to Stimulate Anticancer Immune Response for Preventing Postoperative Tumor Recurrence. Advanced Science, 12(1). https://doi.org/10.1002/advs.202408415

Vancouver

Rao Z, Zhu Y, Chen Z, Luo Y, Yang Z, Liu W, et al. Injectable Autocatalytic Hydrogel Triggers Pyroptosis to Stimulate Anticancer Immune Response for Preventing Postoperative Tumor Recurrence. Advanced Science. 2025;12(1). doi:10.1002/advs.202408415

BibTeX
@article{Rao2025,
  author = {Rao, Zhiping and Zhu, Yutong and Chen, Zhuang and Luo, Yi and Yang, Zuo and Liu, Weijing and Qiao, Chaoqiang and Xia, Yuqiong and Yang, Peng and Ye, Dong-Man and Wang, Zhongliang},
  title = {Injectable Autocatalytic Hydrogel Triggers Pyroptosis to Stimulate Anticancer Immune Response for Preventing Postoperative Tumor Recurrence},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {1},
  doi = {10.1002/advs.202408415}
}
Kostenlos starten →